Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights of Gilead Sciences (GILD) Q2 earnings report

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell.

The revenue increased by 21% to $6.2 billion compared to the previous year.

The net income was $1.52 billion or $1.21 per share compared to a loss of $3.3 billion or $2.66 per share of the same quarter in the previous year.

The adjusted earnings per share were $1.87 compared to $1.11 of the previous year.

Most Popular

A look at Weber’s (WEBR) first quarterly report as a public company

Shares of outdoor grill maker Weber Inc. (NYSE: WEBR) were up 9% on Wednesday after the company released its first quarterly earnings report since going public last month. The stock

Is Crocs (NASDAQ: CROX) stock still a buy after the massive rally?

While throwing markets into disarray, the widespread shutdown also had a positive effect on industries like retail and technology, but there are surprise winners like Crocs, Inc. (NASDAQ: CROX) that

Leaf Mobile CEO Darcy Taylor: Aiming to double game portfolio by year-end

Credit: agrobacter on iStock How do you see the future of mobile gaming revenues – is it going to be primarily from advertisements, or will it be more skewed towards

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top